We are live on
!
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$566M
1-Year Est. Return
197.74%
This Fund
S&P 500
This Quarter
Est. Return
+30.38%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$179M
AUM Growth
+$25.8M
(+17%)
Cap. Flow
-$106K
Cap. Flow
% of AUM
-0.06%
Top 10 Holdings %
Top 10 Hldgs %
49.87%
Holding
82
New
15
Increased
17
Reduced
25
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xencor
XNCR
|
+$3.26M |
| 2 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.11M |
| 3 |
Verizon
VZ
|
+$984K |
| 4 |
SPDR Gold Trust
GLD
|
+$806K |
| 5 |
Target
TGT
|
+$571K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.14M |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.05M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$740K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$639K |
| 5 |
General Motors
GM
|
+$623K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.65% |
| 2 | Miscellaneous | 30.79% |
| 3 | Technology | 15% |
| 4 | Communication Services | 9.15% |
| 5 | Financials | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.2B
| – | – |
-9,500
| Closed | -$732K |
|
77
JPMorgan Chase
JPM
$923B
| – | – |
-5,000
| Closed | -$450K |
|
78
Kohl's
KSS
$1.87B
| – | – |
-17,500
| Closed | -$337K |
|
79
Ovintiv
OVV
$17.4B
| – | – |
-21,000
| Closed | -$57K |
|
80
PUT
AT&T
T
$174B
| – | – |
-113,202
| Closed | -$2.49M |
|
81
PUT
State Street Technology Select Sector SPDR ETF
XLK
$122B
| – | – |
-5,000
| Closed | -$201K |
|
|
XYZ
82
Block Inc
XYZ
$46.5B
| – | – |
-20,000
| Closed | -$1.05M |
|
Similar funds
LT
CIM
B
PCM
LIM
AP
CWA
CA
DCF Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, DCF Advisers held 82 positions worth $179M, up 17% from $153M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
DCF Advisers's Q2 2020 filing shows 15 new, 17 increased, 25 reduced and 12 closed positions. Its largest new stake was Target: 5,000 shares worth $600K. The largest sale was Bristol-Myers Squibb, an estimated $1.14M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Technology.
- DCF Advisers's largest Q2 2020 buy was Target: 5,000 shares worth $600K.
- DCF Advisers added most to Xencor in Q2 2020, an estimated $3.26M increase.
- DCF Advisers's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.14M.
- DCF Advisers fully exited Block Inc in Q2 2020, selling an estimated $1.05M.
- DCF Advisers's ten largest holdings make up 50% of its $179M portfolio in Q2 2020.
- DCF Advisers opened 15 new positions and closed 12 in Q2 2020.
- DCF Advisers's portfolio value rose 17% quarter-over-quarter to $179M.
Based on DCF Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.